William Blair began coverage of Wingstop (NASDAQ:WING) with an Outperform rating, driven by the chain’s consistent sales record, disciplined store model, and room to grow in the U.S. and abroad.

Trump is also threatening a 200% tariff on pharmaceutical imports. So far, pharmaceutical stocks are only showing a mild reaction because the plan appears to be to give about 18 months for ...

The recent Maxwell hard fork, which reduced block times, and the introduction of tokenized equities by Kraken and Backed Finance, have contributed to this growth.